Summary
Taner Arslan is a translational and precision medicine leader with 11 years of experience combining bioinformatics, data science and AI to accelerate drug development and biomarker-driven decision making. With a PhD in Computational Biology from Karolinska Institutet and roles at AstraZeneca and now Chiesi Group, he designs translational strategies, integrates quantitative disciplines, and leads cross-functional teams to strengthen evidence generation. He has a strong track record publishing and presenting at international venues and advancing respiratory disease programs through biomarker and ML-driven insights. Based in Solna, Sweden, he blends academic rigor from SciLifeLab research with industry impact, routinely evaluating emerging technologies and external collaborations to translate complex molecular data into actionable clinical strategies.
11 years of coding experience
6 years of employment as a software developer
Doctor of Philosophy (Ph.D.) Computational Biology, Doctor of Philosophy (Ph.D.) Computational Biology at Karolinska Institutet
Bachelor of Science (B.Sc.) Molecular Biology and Genetics, Bachelor of Science (B.Sc.) Molecular Biology and Genetics at Istanbul University
Master of Science (M.Sc.) Bioinformatics, Master of Science (M.Sc.) Bioinformatics at Universität des Saarlandes
Turkish, English, German